The potential for pharmaceutical sales forces to leverage growth and development of the industry is phenomenal. Over the next few years, pharmaceutical companies will find it severely difficult to increase revenue, due to patent expiries and a lack of new blockbuster drugs coming out of their R&D pipelines. As a result, the industry must scrutinise closely how to increase the ROI of their sales teams. Companies are therefore back to basics, which means relying on the calibre and effectiveness of the sales force whilst applying innovative sales force strategies.
Welcome to KWGroup website
Global Strategy – Regional Experience – Local knowledge
Events and professional media account for the largest proportion of b2b spend globally and define the fact that face to face meetings, networking and professional media offer the best way to drive business globally.
With over 20 years experience KW Group is the leading international business to business boutique events, media and data company, creating high quality, well researched products and services through offices in Europe, America, Asia and The Middle East.
Upcoming Events
-
Pharmaceutical Sales Force Effectiveness
Date: 30 Sept – 1 October 2010Venue: Le Royal Meridien, MumbaiCategory: Upcoming Events -
Effective Vaccine Trials Against Epidemic
Date: 18 – 20 October 2010Venue: A 5-Star Hotel to be confirmed, London, UKCategory: Upcoming EventsThe new epidemic risks are often perceived as more critical than those that have been known for a long time. With latest development and technology, the biotechnology revolution has stimulated increased activity and has witnessed a remarkable pace in the research and development of vaccines and associated technologies for disease control through immunization. Many new diseases have recently become or soon will be vaccine preventable, and improvements to existing vaccines are appearing in rapid succession.
-
Corporate Legal Counsel
Date: 25 – 26 October 2010Venue: JW Marriott Hotel, Kuala LumpurCategory: Upcoming EventsIn today’s challenging business climate, the role and responsibilities of the Corporate Legal Counsel is rapidly changing. These changes are brought forth by new demands: heightened regulatory compliance, higher standards of corporate governance, transparency, business ethics and accountability. Now more than ever, Corporate Legal Counsels need to embrace these changes and reinvent their role to meet these new expectations. The Corporate Legal Counsel’s role today entails having an acute understanding and awareness of the legal implications of each corporate decision and playing an important role as a business advisor to the organisation.
-
Successful Staff Recruitment & Retention Strategies
Date: 28 – 29 October 2010Venue: JW Marriott Hotel, Kuala LumpurCategory: Upcoming EventsThe ability to recruit the right candidates and to deploy them well is a key strategic advantage appreciated by many organisations but implemented by few. Talent-based selection is not new but the art of combining skills, knowledge, experience, expertise together with talent in the sourcing, filtering, and acceptance criteria of candidates is rarely practiced. Too many leaders and managers just do not have the right skills to select the very best, cast these new employees into appropriate job roles, and then to continuously motivate and grow them for organisational and personal excellence.
-
International Heritage Preservation and Structural Repairs
Date: 11 - 12 November 2010Venue: Crowne Plaza Hotel, New Delhi, IndiaCategory: Upcoming EventsPreservation practitioners must now be concerned with the safety of an historic building’s occupants, as well as the security of equipment and data. Preserving historic buildings and sites is an environmentally responsible practice and is essential to understanding a nation’s heritage. Heritage preservation is essentially a recycling program of ‘historic’ proportions. Existing buildings can often be energy efficient through their use of good ventilation, durable materials, and spatial relationships.
-
Synergistic SuperGrid for Transmitting Energy Overseas 2011
Date: 19 – 21 January 2011Venue: A 5-Star Hotel to be confirmed, London, UKCategory: Upcoming EventsOver the past years a number of discussions took place in order to evaluate opportunities for the development of a Supergrid. The following concept would bring together the latest technology in solar & wind power in order to ensure a secure supply of electricity in between the European Union & North Africa. Europe has the world’s prosperous wind resources and the most sophisticated technologies to guarantee a progress in transforming wind and solar power into electricity. With a SuperGrid in place, the European Union would be able to overcome the major barriers on the way to create a single electricity market and offer an effective electricity supply to its Member States.
-
Global Renewable Energy Development – Investments and Opportunities
Date: 7 – 8 February 2011Venue: A 5-Star hotel to be confirmed, London, UKRenewable energy and energy efficient technology is growing rapidly to be a large part of the world’s energy future. The public and private sector investment in renewable energy have demonstrated an increased interest in renewable energy. The increased awareness of renewable energy opportunities and government policies supportive of renewable energy development are helping to speed this transition to a sustainable energy future.
-
Global Life Sciences M&A and Strategic Alliances
Date: 18 - 19 October 2010Venue: Grand Copthone Waterfront Hotel, SingaporeCategory: Upcoming EventsLife Sciences companies are undergoing a strategic rethink as they consider how best to access innovation, initiate process change to better prepare the business for existing and future market and regulatory changes, and ultimately improve productivity and efficiency. The orientation of business relationship is changing as a result, with an eye toward the long-term and an emphasis on the concept of partnership. The pharma industry has experienced a convergence of factors that has impacted the way it does business. While doing deals with biotech companies and outsourcing several strategic, albeit non-core capabilities, it is only more recently that changing market dynamics have evolved pharma companies to adopt a more collaborative approach. The result is a new wave of partnerships at both the R&D level and in other key functions within the organisation.
